Xylocare-ADR Injection is a sterile solution containing Lidocaine 2% w/v and Adrenaline 0.001% w/v, formulated for local anesthesia with vasoconstrictive properties. Lidocaine, a widely used amide-type local anesthetic, acts by blocking sodium ion channels in neuronal membranes, thereby inhibiting nerve impulse conduction and providing effective analgesia. The addition of Adrenaline, a potent vasoconstrictor, prolongs the anesthetic effect by reducing systemic absorption of Lidocaine, minimizing bleeding at the site of administration, and enhancing the duration of anesthesia. Xylocare-ADR is indicated for infiltration, nerve block, and regional anesthesia in various surgical, dental, and diagnostic procedures requiring localized numbness. It is particularly beneficial in procedures where prolonged anesthesia and reduced bleeding are desired. The injection should be administered by trained healthcare professionals, with careful consideration of contraindications such as hypersensitivity to amide anesthetics or adrenaline, severe cardiovascular disorders, and certain arrhythmias. Dosage and administration must be tailored to the patient's condition, weight, and procedure type to avoid systemic toxicity. Adverse effects may include local irritation, systemic toxicity manifesting as CNS or cardiovascular symptoms, and allergic reactions. Proper monitoring during and after administration is essential to ensure patient safety.